Pfizer

A meaningful impact on patient care

Biologic medicines, including biosimilars, come in different forms, such as monoclonal antibodies and growth factors. Their capacity to precisely target signaling pathways and cells is revolutionizing the battle against challenging disease areas, including cancer and inflammation.

Biologics have been used successfully to treat many different
life-threatening and chronic diseases

Expanding options

As potential alternatives to reference biologics, biosimilars may potentially expand treatment options to meet the growing demand for biologic therapies.
PREVIOUS:
Biosimilars Potential Value
NEXT:
Health care system benefits
Close
Close

You are now leaving Pfizer

Links to sites outside of Pfizer are provided as a resource to the viewer. Pfizer accepts no responsibility for the content of linked sites.

OK CANCEL
Close

You are now leaving PfizerBiosimilars.com.

The information provided in biosimilars.pfizerpro.com is intended only for healthcare professionals in the United States. The products discussed may have different product labeling in different countries.

CONTINUE CANCEL
Close